MedTrace Logo

Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor

NCT02090920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2019-06-26

No results posted yet for this study

Summary

This study looks at the effects of a mother's genes and other characteristics (mother's age, baby's age, race, and other diseases) on the ability of nifedipine to end contractions and prevent an early delivery. This information will be used to decide what amount of nifedipine women need to best treat preterm contractions.

Conditions

  • Preterm Labor

Interventions

DRUG

Nifedipine

Nifedipine 10 mg immediate release tablet by mouth loading dose Nifedipine administered orally every 15-20 minutes for the first hour to a maximum loading dose of 30 mg, followed by a maintenance dose of 10-20 mg immediate release nifedipine administered orally every 6 hours

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Sara Quinney, PharmD, PhD · Indiana University Clinical Pharmacology

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2016-05-31
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02090920 on ClinicalTrials.gov